Pharma IQ News
The Reputation Institute has revealed the top 10 most reputable pharma companies as voted by the general public. In a surprising result, AstraZeneca and GSK both failed to make the top 10.
Pharma IQ brings you a round up of the latest developments within the Pharma and Biotech industries.
Labelled as one of the globe’s fastest growing pharmaceutical markets, Russia’s medicinal industry is set to rise from 2016’s value of $20.91 billion in 2016 to $38.56 billion by 2021, representing a compound annual growth rate of 13%, according to research firm GlobalData.
Following a quarter that featured reports stating that Novartis had dramatically redistributed its cell and gene therapy unit 1 and saw the public focus turn once again to drug price hikes, Pharma IQ brings you the pharma, biotech and life sciences news highlights for Q3 of 2016.
A new technology referred to as an artificial nose has the ability to detect a rare progressive lung disease from a patient’s breath.
19th Software Design for Medical Devices Summit is pleased to announce the chairman of the Summit Mr. Phani Bidarahalli, GM & Head of Healthcare Engineering at Wipro. He will be joined by the expert speaker faculty including senior executive from GE Healthcare, Philips Healthcare, Medtronic and more this May 11 – 12, at The Hotel Kabuki... Read more
Pharmaceuticals consistently rank within the top ten categories for counterfeit goods and the risk to products can vary from country to country. In response pharmaceutical manufacturers are investing more in product security initiatives, such as serialisation which involves coding products uniquely at the item level.
A recent report has identified the biggest causes of UK healthcare and pharmaceutical professionals’ delays and distractions at work. Of the professionals asked about interruptions to their working day, more than two fifths (43%) identified traffic jams as a productivity killer.
A pioneering new combined cell-gene therapy to treat lung cancer will be tested in NHS patients this year, after receiving £2m of Biomedical Catalyst funding from the Medical Research Council (MRC).